Prime editing corrects the dilated cardiomyopathy causing RBM20-P633L-mutation in human cardiomyocytes
Open Access
- 7 October 2025
- journal article
- Published by Elsevier in Molecular Therapy Nucleic Acids
- Vol. 36 (4) , 102734
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Integrating Prime Editing and Cellular Reprogramming as Novel Strategies for Genetic Cardiac Disease Modeling and TreatmentCurrent Cardiology Reports, 2024
- Phage-assisted evolution and protein engineering yield compact, efficient prime editorsCell, 2023
- The penetrance of rare variants in cardiomyopathy-associated genes: A cross-sectional approach to estimating penetrance for secondary findingsThe American Journal of Human Genetics, 2023
- Prediction of efficiencies for diverse prime editing systems in multiple cell typesCell, 2023
- Enhanced prime editing systems by manipulating cellular determinants of editing outcomesCell, 2021
- Simple Workflow and Comparison of Media for hPSC‐Cardiomyocyte Cryopreservation and RecoveryCurrent Protocols in Stem Cell Biology, 2020
- iPSC Modeling of RBM20-Deficient DCM Identifies Upregulation of RBM20 as a Therapeutic StrategyCell Reports, 2020
- Genetic variation in the alternative splicing regulator RBM20 is associated with dilated cardiomyopathyHeart Rhythm, 2012
- Mutations in Ribonucleic Acid Binding Protein Gene Cause Familial Dilated CardiomyopathyJACC, 2009
- Lamin A/C mutation analysis in a cohort of 324 unrelated patients with idiopathic or familial dilated cardiomyopathyAmerican Heart Journal, 2008